ANI Pharmaceuticals Inc (ANIP)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 614,376 | 486,816 | 316,385 | 216,136 | 208,475 |
| Property, plant and equipment | US$ in thousands | — | — | 43,246 | 52,671 | 41,269 |
| Fixed asset turnover | — | — | 7.32 | 4.10 | 5.05 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $614,376K ÷ $—K
= —
The fixed asset turnover ratio for ANI Pharmaceuticals Inc has fluctuated over the years according to the available data. It stood at 5.05 as of December 31, 2020, indicating that the company generated $5.05 in revenue for every dollar invested in fixed assets during that period.
Subsequently, the ratio decreased to 4.10 by December 31, 2021, suggesting a decrease in efficiency in utilizing fixed assets to generate revenue. However, there was a significant improvement in the ratio, reaching 7.32 by December 31, 2022, which could indicate better asset management or increased sales efficiency.
Unfortunately, the data for December 31, 2023, and December 31, 2024, is unavailable (denoted as "—"), making it challenging to provide a comprehensive trend analysis for those years.
In conclusion, ANI Pharmaceuticals Inc has shown varying levels of efficiency in utilizing its fixed assets to generate revenue over the years, with notable improvements in certain periods. It would be beneficial to assess the company's operating performance and asset utilization in conjunction with other financial metrics for a more holistic analysis of its financial health.
Peer comparison
Dec 31, 2024